Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $6.17 USD
Change Today -0.13 / -2.06%
Volume 214.6K
ECYT On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Philip S. Low Ph.D.

Co-Founder, Chief Scientific Officer and Director, Endocyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 2 different organizations across 2 different industries.

See Board Relationships
66$697,613
As of Fiscal Year 2014

Background*

Dr. Philip S. Low, PhD is a Founder of Endocyte, Inc. and has been its Chief Scientific Officer since April 1998. Dr. Low serves as Joseph F. Foster Professor of Chemistry and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. Dr. Low has spent over 14 years in drug delivery research. He has been a Director of Endocyte, Inc. since December 1995. He serves as Member of Scientific Advisory Board at IVDiagnostics, Inc. He has served National Institutes ...

Read Full Background

Corporate Headquarters*

3000 Kent Avenue
West Lafayette, Indiana 47906

United States

Phone: 765-463-7175
Fax: 765-463-9271

Board Members Memberships*

1995-Present
Co-Founder, Chief Scientific Officer and Director

Education*

PhD 1975
University of California - San Diego
BS
Brigham Young University

Other Affiliations*

Annual Compensation*

Salary$208,718
Total Annual Compensation$208,718

Stock Options*

Restricted Stock Awards$83,325
All Other Compensation$840
Exercisable Options277,988
Unexercisable Options150,000
Total Number of Options427,988

Total Compensation*

Total Annual Cash Compensation$209,558
Total Short Term Compensation$208,718
Other Long Term Compensation$84,165
Total Calculated Compensation$697,613
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECYT:US $6.17 USD -0.13

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDOCYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.